Loading…

Sertoli-leydig cell tumour of ovary with menorrhagia: a rare case report

Sertoli-Leydig cell tumours (SLCTs) are rare sex cord stromal neoplasms of ovary accounting for less than 0.5% of all ovarian tumours. These are found in women of all age groups (2-75 y), but are most common in reproductive age group with an average age of 25 y. Mostly these are unilateral, confined...

Full description

Saved in:
Bibliographic Details
Published in:Journal of clinical and diagnostic research 2014-10, Vol.8 (10), p.FD18-FD20
Main Authors: Kanade, Umesh Sidheshwar, Dantkale, Sunita Sanjay, Narkhede, Rahul Ravindra, Kurawar, Rupali Ramrao, Bansode, Shubhada Yadavrao
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page FD20
container_issue 10
container_start_page FD18
container_title Journal of clinical and diagnostic research
container_volume 8
creator Kanade, Umesh Sidheshwar
Dantkale, Sunita Sanjay
Narkhede, Rahul Ravindra
Kurawar, Rupali Ramrao
Bansode, Shubhada Yadavrao
description Sertoli-Leydig cell tumours (SLCTs) are rare sex cord stromal neoplasms of ovary accounting for less than 0.5% of all ovarian tumours. These are found in women of all age groups (2-75 y), but are most common in reproductive age group with an average age of 25 y. Mostly these are unilateral, confined to ovaries and usually stage I at the time of clinical diagnosis. The common presenting complaints in these patients are due to either mass occupying lesion (mostly pelviabdominal mass and/or pain) or hormonal production (mostly androgen and more rarely oestrogen). Androgenic manifestations, seen in 80% of patients with SLCT, are virilism, hirsutism, receding hairline, breast atrophy, clitoromegaly, acne, hoarseness of voice, etc. Estrogenic manifestations are precocious puberty, abnormal uterine bleeding, abnormal vaginal bleeding, menstrual irregularities, generalised oedema, weight gain, breast hypertrophy, endometrial hyperplasia, endometrial polyps and endometrial carcinoma. Histologically these are classified (WHO) as well-differentiated, intermediately differentiated, poorly differentiated, with heterologous components and retiform type. Prognosis depends upon degree of tumour differentiation (grading) and tumour extent (staging). We herein report an unusual case of SLCT of ovary with oestrogenic manifestation of menorrhagia.
doi_str_mv 10.7860/JCDR/2014/9394.5014
format article
fullrecord <record><control><sourceid>pubmed_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_9560ec4540224447b0a3106bcdee814e</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_9560ec4540224447b0a3106bcdee814e</doaj_id><sourcerecordid>25478358</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3034-196fcace2043acfc4664d6870093f4fd8618323f8057f79fe329841be840e5313</originalsourceid><addsrcrecordid>eNpVkdtqGzEQhkVJady0TxAIeoGNR9KsDrkIBKdtUgKFHiB3QtaO7A1ry2jXCXn77tZtaK5GjPg__ehj7FTAubEa5l8X19_nEgTOnXJ4Xo-nN2wGzqjKgLs_YjMp0VXGyvtj9r7vHwC01kq_Y8eyRmNVbWfs5geVIXdt1dFz0654pK7jw36T94XnxPNjKM_8qR3WfEPbXMo6rNpwwQMvoRCPoSdeaJfL8IG9TaHr6ePfecJ-ff70c3FT3X37cru4uquiAoWVcDrFEEkCqhBTRK2x0dYAOJUwNVYLq6RKFmqTjEukpLMolmQRqFZCnbDbA7fJ4cHvSrsZG_ocWv9nkcvKhzK0sSPvag0UsUYYPwLRLCEoAXoZGyIrkEbW5YG12y831ETaDiV0r6Cvb7bt2q_yo0c5VjF6BKgDIJbc94XSS1aAnyT5SZKfJPlJkp8kjamz_599yfyzon4DKcaNkg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Sertoli-leydig cell tumour of ovary with menorrhagia: a rare case report</title><source>PubMed Central Free</source><creator>Kanade, Umesh Sidheshwar ; Dantkale, Sunita Sanjay ; Narkhede, Rahul Ravindra ; Kurawar, Rupali Ramrao ; Bansode, Shubhada Yadavrao</creator><creatorcontrib>Kanade, Umesh Sidheshwar ; Dantkale, Sunita Sanjay ; Narkhede, Rahul Ravindra ; Kurawar, Rupali Ramrao ; Bansode, Shubhada Yadavrao</creatorcontrib><description>Sertoli-Leydig cell tumours (SLCTs) are rare sex cord stromal neoplasms of ovary accounting for less than 0.5% of all ovarian tumours. These are found in women of all age groups (2-75 y), but are most common in reproductive age group with an average age of 25 y. Mostly these are unilateral, confined to ovaries and usually stage I at the time of clinical diagnosis. The common presenting complaints in these patients are due to either mass occupying lesion (mostly pelviabdominal mass and/or pain) or hormonal production (mostly androgen and more rarely oestrogen). Androgenic manifestations, seen in 80% of patients with SLCT, are virilism, hirsutism, receding hairline, breast atrophy, clitoromegaly, acne, hoarseness of voice, etc. Estrogenic manifestations are precocious puberty, abnormal uterine bleeding, abnormal vaginal bleeding, menstrual irregularities, generalised oedema, weight gain, breast hypertrophy, endometrial hyperplasia, endometrial polyps and endometrial carcinoma. Histologically these are classified (WHO) as well-differentiated, intermediately differentiated, poorly differentiated, with heterologous components and retiform type. Prognosis depends upon degree of tumour differentiation (grading) and tumour extent (staging). We herein report an unusual case of SLCT of ovary with oestrogenic manifestation of menorrhagia.</description><identifier>ISSN: 2249-782X</identifier><identifier>EISSN: 0973-709X</identifier><identifier>DOI: 10.7860/JCDR/2014/9394.5014</identifier><identifier>PMID: 25478358</identifier><language>eng</language><publisher>India: JCDR Research and Publications (P) Limited</publisher><subject>menorrhagia ; Pathology Section ; sertoli-leydig cell tumour ; sex cord stromal tumour</subject><ispartof>Journal of clinical and diagnostic research, 2014-10, Vol.8 (10), p.FD18-FD20</ispartof><rights>2014 Journal of Clinical and Diagnostic Research 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4253176/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4253176/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25478358$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kanade, Umesh Sidheshwar</creatorcontrib><creatorcontrib>Dantkale, Sunita Sanjay</creatorcontrib><creatorcontrib>Narkhede, Rahul Ravindra</creatorcontrib><creatorcontrib>Kurawar, Rupali Ramrao</creatorcontrib><creatorcontrib>Bansode, Shubhada Yadavrao</creatorcontrib><title>Sertoli-leydig cell tumour of ovary with menorrhagia: a rare case report</title><title>Journal of clinical and diagnostic research</title><addtitle>J Clin Diagn Res</addtitle><description>Sertoli-Leydig cell tumours (SLCTs) are rare sex cord stromal neoplasms of ovary accounting for less than 0.5% of all ovarian tumours. These are found in women of all age groups (2-75 y), but are most common in reproductive age group with an average age of 25 y. Mostly these are unilateral, confined to ovaries and usually stage I at the time of clinical diagnosis. The common presenting complaints in these patients are due to either mass occupying lesion (mostly pelviabdominal mass and/or pain) or hormonal production (mostly androgen and more rarely oestrogen). Androgenic manifestations, seen in 80% of patients with SLCT, are virilism, hirsutism, receding hairline, breast atrophy, clitoromegaly, acne, hoarseness of voice, etc. Estrogenic manifestations are precocious puberty, abnormal uterine bleeding, abnormal vaginal bleeding, menstrual irregularities, generalised oedema, weight gain, breast hypertrophy, endometrial hyperplasia, endometrial polyps and endometrial carcinoma. Histologically these are classified (WHO) as well-differentiated, intermediately differentiated, poorly differentiated, with heterologous components and retiform type. Prognosis depends upon degree of tumour differentiation (grading) and tumour extent (staging). We herein report an unusual case of SLCT of ovary with oestrogenic manifestation of menorrhagia.</description><subject>menorrhagia</subject><subject>Pathology Section</subject><subject>sertoli-leydig cell tumour</subject><subject>sex cord stromal tumour</subject><issn>2249-782X</issn><issn>0973-709X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkdtqGzEQhkVJady0TxAIeoGNR9KsDrkIBKdtUgKFHiB3QtaO7A1ry2jXCXn77tZtaK5GjPg__ehj7FTAubEa5l8X19_nEgTOnXJ4Xo-nN2wGzqjKgLs_YjMp0VXGyvtj9r7vHwC01kq_Y8eyRmNVbWfs5geVIXdt1dFz0654pK7jw36T94XnxPNjKM_8qR3WfEPbXMo6rNpwwQMvoRCPoSdeaJfL8IG9TaHr6ePfecJ-ff70c3FT3X37cru4uquiAoWVcDrFEEkCqhBTRK2x0dYAOJUwNVYLq6RKFmqTjEukpLMolmQRqFZCnbDbA7fJ4cHvSrsZG_ocWv9nkcvKhzK0sSPvag0UsUYYPwLRLCEoAXoZGyIrkEbW5YG12y831ETaDiV0r6Cvb7bt2q_yo0c5VjF6BKgDIJbc94XSS1aAnyT5SZKfJPlJkp8kjamz_599yfyzon4DKcaNkg</recordid><startdate>20141001</startdate><enddate>20141001</enddate><creator>Kanade, Umesh Sidheshwar</creator><creator>Dantkale, Sunita Sanjay</creator><creator>Narkhede, Rahul Ravindra</creator><creator>Kurawar, Rupali Ramrao</creator><creator>Bansode, Shubhada Yadavrao</creator><general>JCDR Research and Publications (P) Limited</general><general>JCDR Research and Publications Private Limited</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20141001</creationdate><title>Sertoli-leydig cell tumour of ovary with menorrhagia: a rare case report</title><author>Kanade, Umesh Sidheshwar ; Dantkale, Sunita Sanjay ; Narkhede, Rahul Ravindra ; Kurawar, Rupali Ramrao ; Bansode, Shubhada Yadavrao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3034-196fcace2043acfc4664d6870093f4fd8618323f8057f79fe329841be840e5313</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>menorrhagia</topic><topic>Pathology Section</topic><topic>sertoli-leydig cell tumour</topic><topic>sex cord stromal tumour</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kanade, Umesh Sidheshwar</creatorcontrib><creatorcontrib>Dantkale, Sunita Sanjay</creatorcontrib><creatorcontrib>Narkhede, Rahul Ravindra</creatorcontrib><creatorcontrib>Kurawar, Rupali Ramrao</creatorcontrib><creatorcontrib>Bansode, Shubhada Yadavrao</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals (Open Access)</collection><jtitle>Journal of clinical and diagnostic research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kanade, Umesh Sidheshwar</au><au>Dantkale, Sunita Sanjay</au><au>Narkhede, Rahul Ravindra</au><au>Kurawar, Rupali Ramrao</au><au>Bansode, Shubhada Yadavrao</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sertoli-leydig cell tumour of ovary with menorrhagia: a rare case report</atitle><jtitle>Journal of clinical and diagnostic research</jtitle><addtitle>J Clin Diagn Res</addtitle><date>2014-10-01</date><risdate>2014</risdate><volume>8</volume><issue>10</issue><spage>FD18</spage><epage>FD20</epage><pages>FD18-FD20</pages><issn>2249-782X</issn><eissn>0973-709X</eissn><abstract>Sertoli-Leydig cell tumours (SLCTs) are rare sex cord stromal neoplasms of ovary accounting for less than 0.5% of all ovarian tumours. These are found in women of all age groups (2-75 y), but are most common in reproductive age group with an average age of 25 y. Mostly these are unilateral, confined to ovaries and usually stage I at the time of clinical diagnosis. The common presenting complaints in these patients are due to either mass occupying lesion (mostly pelviabdominal mass and/or pain) or hormonal production (mostly androgen and more rarely oestrogen). Androgenic manifestations, seen in 80% of patients with SLCT, are virilism, hirsutism, receding hairline, breast atrophy, clitoromegaly, acne, hoarseness of voice, etc. Estrogenic manifestations are precocious puberty, abnormal uterine bleeding, abnormal vaginal bleeding, menstrual irregularities, generalised oedema, weight gain, breast hypertrophy, endometrial hyperplasia, endometrial polyps and endometrial carcinoma. Histologically these are classified (WHO) as well-differentiated, intermediately differentiated, poorly differentiated, with heterologous components and retiform type. Prognosis depends upon degree of tumour differentiation (grading) and tumour extent (staging). We herein report an unusual case of SLCT of ovary with oestrogenic manifestation of menorrhagia.</abstract><cop>India</cop><pub>JCDR Research and Publications (P) Limited</pub><pmid>25478358</pmid><doi>10.7860/JCDR/2014/9394.5014</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2249-782X
ispartof Journal of clinical and diagnostic research, 2014-10, Vol.8 (10), p.FD18-FD20
issn 2249-782X
0973-709X
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_9560ec4540224447b0a3106bcdee814e
source PubMed Central Free
subjects menorrhagia
Pathology Section
sertoli-leydig cell tumour
sex cord stromal tumour
title Sertoli-leydig cell tumour of ovary with menorrhagia: a rare case report
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T11%3A09%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sertoli-leydig%20cell%20tumour%20of%20ovary%20with%20menorrhagia:%20a%20rare%20case%20report&rft.jtitle=Journal%20of%20clinical%20and%20diagnostic%20research&rft.au=Kanade,%20Umesh%20Sidheshwar&rft.date=2014-10-01&rft.volume=8&rft.issue=10&rft.spage=FD18&rft.epage=FD20&rft.pages=FD18-FD20&rft.issn=2249-782X&rft.eissn=0973-709X&rft_id=info:doi/10.7860/JCDR/2014/9394.5014&rft_dat=%3Cpubmed_doaj_%3E25478358%3C/pubmed_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3034-196fcace2043acfc4664d6870093f4fd8618323f8057f79fe329841be840e5313%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/25478358&rfr_iscdi=true